SELARL PHARMACIE DE L'HOTEL DE VILLE : revenue, balance sheet and financial ratios

SELARL PHARMACIE DE L'HOTEL DE VILLE is a French company founded 17 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LE QUESNOY (59530), this company of category PME shows in 2018 a revenue of 1.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DE L'HOTEL DE VILLE (SIREN 504312794)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C 1 651 761 € 1 626 773 € 1 680 355 €
Net income 532 122 € 114 561 € 234 746 € 110 846 € 103 488 € 120 206 € 88 772 € 104 541 € 144 405 €
EBITDA N/C N/C N/C N/C N/C N/C 92 035 € 112 986 € 148 516 €
Net margin N/C N/C N/C N/C N/C N/C 5.4% 6.4% 8.6%

Revenue and income statement

In 2024, SELARL PHARMACIE DE L'HOTEL DE VILLE generates positive net income of 532 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 144 k€ -> 532 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

532 122 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 28%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

28.307%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

67.965%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

33.8%

Solvency indicators evolution
SELARL PHARMACIE DE L'HOTEL DE VILLE

Sector positioning

Debt ratio
28.31 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good -10 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE DE L'HOT... (28.31) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
67.97% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +15 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMACIE DE L'HOT... (68.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 154.85. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

154.846

Liquidity indicators evolution
SELARL PHARMACIE DE L'HOTEL DE VILLE

Sector positioning

Liquidity ratio
154.85 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average -6 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMACIE DE L'HOT... (154.85) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DE L'HOTEL DE VILLE

Positioning of SELARL PHARMACIE DE L'HOTEL DE VILLE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL PHARMACIE DE L'HOTEL DE VILLE is estimated at 7 428 816 € (range 5 173 310€ - 11 113 934€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
5173k€ 7428k€ 11113k€
7 428 816 € Range: 5 173 310€ - 11 113 934€
NAF 5 année 2024

Valuation method used

Net Income Multiple
532 122 € × 14.0x = 7 428 817 €
Range: 5 173 310€ - 11 113 935€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DE L'HOTEL DE VILLE with other companies in the same sector:

Frequently asked questions about SELARL PHARMACIE DE L'HOTEL DE VILLE

What is the revenue of SELARL PHARMACIE DE L'HOTEL DE VILLE ?

The revenue of SELARL PHARMACIE DE L'HOTEL DE VILLE in 2018 is 1.7 M€.

Is SELARL PHARMACIE DE L'HOTEL DE VILLE profitable?

Yes, SELARL PHARMACIE DE L'HOTEL DE VILLE generated a net profit of 532 k€ in 2024.

Where is the headquarters of SELARL PHARMACIE DE L'HOTEL DE VILLE ?

The headquarters of SELARL PHARMACIE DE L'HOTEL DE VILLE is located in LE QUESNOY (59530), in the department Nord.

Where to find the tax return of SELARL PHARMACIE DE L'HOTEL DE VILLE ?

The tax return of SELARL PHARMACIE DE L'HOTEL DE VILLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DE L'HOTEL DE VILLE operate?

SELARL PHARMACIE DE L'HOTEL DE VILLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.